GDF15 also distinguished the PVOD cohort from the combined IPAH, HPAH, and Other PH cohort and the combined IPAH and HPAH cohort, with an optimal cutoff value of 1,658 pg/mL and 81% sensitivity and 98% specificity. This evidence concerns the gene GDF15 and pulmonary venoocclusive disease.